Malignant Meningioma
📧 Sign up to get email alerts when something new happens for Malignant Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma [EARLY_Phase 1]
A Phase 1 clinical trial evaluating γδ T-PD-1 Ab Cells for malignant meningioma; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers [Phase 2]
A Phase 2 trial of nivolumab in patients with recurrent select rare CNS cancers (medulloblastoma, ependymoma, pineal region tumors, choroid …
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma [NA]
A clinical trial update announcing ongoing recruitment for adjuvant hypofractionated stereotactic radiosurgery in intermediate-risk meningio…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults [NA]
Clinical trial update indicating Apatinib is being studied for recurrent atypical or malignant meningioma in adults; the study is currently …
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: Cellular Immunotherapy Study for Brain Cancer [Phase 1]
Phase 1 clinical trial update describes completion of a cellular immunotherapy study for brain tumors to assess safety and initial signals o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Phase 2]
Phase 2 SWOG trial of ifosfamide for meningeal tumors and related sarcomas was terminated.